Stimulation of β3‐adrenoceptors causes phosphorylation of p38 mitogen‐activated protein kinase via a stimulatory G protein‐dependent pathway in 3T3‐L1 adipocytes
Authors:
- 2 February 2002
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 135 (4) , 951-960
Abstract
This study deals with phosphorylation and activation of p38 mitogen‐activated protein kinase (MAPK) via β3‐adrenoceptor (AR) and the signal transduction pathway in 3T3‐L1 adipocytes. β3‐AR agonist BRL37344A (10 nM) caused phosphorylation and activation of p38 MAPK in 3T3‐L1 adipocytes but not in fibroblasts. BRL37344A and also the other β3‐AR agonists, CGP12177A and SR58611A, caused p38 MAPK phosphorylation in dose‐dependent manners. The p38 MAPK phosphorylations by BRL37344A (10 nM), CGP12177A (100 nM), and SR58611A (10 nM) were not antagonized by β1‐ and β2‐ARs antagonist 1‐propranolol (100 nM) but blocked by β3‐AR antagonist SR59230A (10 μM), suggesting the phosphorylation was caused via β3‐AR. The phosphorylations of p38 MAPK were completely abolished by treatment with cholera toxin (CTX) but not pertussis toxin (100 ng ml−1, 24 h). Activation of Gs by CTX (100 ng ml−1) and adenylyl cyclase by forskolin mimicked p38 MAPK phosphorylation. p38 MAPK phosphorylation by BRL37344A was reduced to almost 50% by cyclic AMP‐dependent protein kinase (PKA) inhibitors such as H89 (10 μM) and PKI (10 μM). A src‐family tyrosine kinases inhibitor PP2 (1 μM) also halved the p38 MAPK phosphorylation. Combined use of H89 (10 μM) and PP2 (10 μM) did not bring about further inhibition. These results suggest that β3‐AR caused phosphorylation of p38 MAPK via Gs protein and partly through a pathway involving PKA and src‐family kinase(s), although the contribution of the unidentified pathway remains to be clarified. British Journal of Pharmacology (2002) 135, 951–960; doi:10.1038/sj.bjp.0704537Keywords
This publication has 50 references indexed in Scilit:
- β-Adrenergic Activation of p38 MAP Kinase in AdipocytesJournal of Biological Chemistry, 2001
- Analysis of inhibition by H89 of UCP1 gene expression and thermogenesis indicates protein kinase A mediation of β3-adrenergic signalling rather than β3-adrenoceptor antagonism by H89Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2001
- Thrombin‐induced p38 mitogen‐activated protein kinase activation is mediated by epidermal growth factor receptor transactivation pathwayBritish Journal of Pharmacology, 2001
- Prodrugs of CL316243: a selective β3-adrenergic receptor agonist for treating obesity and diabetesBioorganic & Medicinal Chemistry Letters, 1999
- The β3-Adrenergic Receptor Activates Mitogen-activated Protein Kinase in Adipocytes through a Gi-dependent MechanismJournal of Biological Chemistry, 1999
- The activation of p38 MAPK by the β‐adrenergic agonist isoproterenol in rat epididymal fat cellsFEBS Letters, 1998
- Activation of Mitogen-Activated Protein Kinase by Norepinephrine in Brown Adipocytes from RatsEndocrinology, 1997
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996
- cAMP-dependent protein kinase activation mediated by β3-adrenergic receptors parallels lipolysis in rat adipocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
- Chronic exposure of rat glioma C6 cells to cholera toxin induces loss of the α-subunit of the stimulatory guanine nucleotide-binding protein (Gs)European Journal of Pharmacology: Molecular Pharmacology, 1990